Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

DuPont (Dymel Pharma Business)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of pharmaceuticals. The company offers medicines used in the treatment of HIV, cardiovascular disease, central nervous system disorders, cancer and inflammatory diseases.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 1007 Market Street
  • Wilmington, DE 19898
  • United States

DuPont (Dymel Pharma Business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore DuPont (Dymel Pharma Business)‘s full profile, request access.

Request full access to PitchBook